IT1243368B - Use of bendazac and of its pharmaceutically acceptable salts
- Google Patents
Use of bendazac and of its pharmaceutically acceptable salts
Info
Publication number
IT1243368B
IT1243368BIT02107690AIT2107690AIT1243368BIT 1243368 BIT1243368 BIT 1243368BIT 02107690 AIT02107690 AIT 02107690AIT 2107690 AIT2107690 AIT 2107690AIT 1243368 BIT1243368 BIT 1243368B
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AcraffiledCriticalAcraf
Priority to IT02107690ApriorityCriticalpatent/IT1243368B/en
Publication of IT9021076A0publicationCriticalpatent/IT9021076A0/en
Publication of IT9021076A1publicationCriticalpatent/IT9021076A1/en
Application grantedgrantedCritical
Publication of IT1243368BpublicationCriticalpatent/IT1243368B/en
Complexes of 4-hydroxy-2-methyl-N-2-piridinyl-2-H,2-benzothiazine-3-carboxamide-1,1-dioxide with cyclodextrin, with anti-inflammatory action, procedure for their preparation and relevant pharmaceutical composition
Pharmaceutical composition for treatment of ulcer type disorders of gastro-intestinal tract, comprises methyl polysiloxanol and solvent or carrier pharmaceutically acceptable for oral use
Pharmaceutical composition for the treatment of psychical disorders containing D-2-bromo-1,6- dimethyl-8beta-(perhydroazepinyl- carbonyloxymethyl) ergoline or its salts